We have also noted that the higher was the tumor mutation load, the lower was the expression of CDKN2A. We found that tumors with TP53 mutations or high mutation load had lower expression of pro-apoptotic and senescence genes than tumors with wild-type TP53 or low mutation load. This evidence concerns the gene CDKN2A and neoplasm.